Best Practices in the Management of Overweight and Obesity

被引:64
作者
Tchang, Beverly G. [1 ]
Saunders, Katherine H. [1 ]
Igel, Leon I. [1 ]
机构
[1] Weill Cornell Med Coll, Dept Internal Med, Div Endocrinol, 1165 York Ave, New York, NY 10065 USA
关键词
Weight; Overweight; Obesity; Antiobesity medication; Bariatric surgery; Diet; Nutrition; Exercise; CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE; LIFE-STYLE INTERVENTION; RESTING METABOLIC-RATE; WEIGHT-LOSS; CLINICAL-PRACTICE; LOW-CARBOHYDRATE; GLYCEMIC PARAMETERS; PRACTICE GUIDELINES; AMERICAN-COLLEGE; RISK-FACTORS;
D O I
10.1016/j.mcna.2020.08.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity is a chronic disease caused by dysregulated energy homeostasis pathways that encourage the accumulation of adiposity, which in turn results in the development or exacerbation of weight-related comorbidities. Treatment of obesity relies on a foundation of lifestyle modification; weight loss pharmacotherapy, bariatric surgery and devices are additional tools to help patients achieve their health goals. Appropriate management of patients with obesity provides multiple metabolic benefits beyond weight loss. © 2020 Elsevier Inc.
引用
收藏
页码:149 / 174
页数:26
相关论文
共 81 条
[1]   Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP) [J].
Allison, David B. ;
Gadde, Kishore M. ;
Garvey, William Timothy ;
Peterson, Craig A. ;
Schwiers, Michael L. ;
Najarian, Thomas ;
Tam, Peter Y. ;
Troupin, Barbara ;
Day, Wesley W. .
OBESITY, 2012, 20 (02) :330-342
[3]  
American Society for Metabolic and Bariatric Surgery, 2018, EST BAR SURG NUMB
[4]  
[Anonymous], 2015, **NON-TRADITIONAL**
[5]  
[Anonymous], 2016, OBALON BALLOON SYSTE
[6]  
[Anonymous], 2013, BRIT J NUTR, DOI DOI 10.1017/S0007114513000548
[7]  
[Anonymous], 2019, TRANSPYLORIC SHUTTLE
[8]  
[Anonymous], 2016, ASPIREASSIST
[9]   Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline [J].
Apovian, Caroline M ;
Aronne, Louis J. ;
Bessesen, Daniel H. ;
McDonnell, Marie E. ;
Murad, M. Hassan ;
Pagotto, Uberto ;
Ryan, Donna H. ;
Still, Christopher D. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (02) :342-362
[10]   A Randomized, Phase 3 Trial of Naltrexone SR/Bupropion SR on Weight and Obesity-related Risk Factors (COR-II) [J].
Apovian, Caroline M. ;
Aronne, Louis ;
Rubino, Domenica ;
Still, Christopher ;
Wyatt, Holly ;
Burns, Colleen ;
Kim, Dennis ;
Dunayevich, Eduardo .
OBESITY, 2013, 21 (05) :935-943